BioLoomics, Inc. — Form D
BioLoomics, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-13. The offering totals $10.0M, of which $9.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-03-13
- Form: D
- Accession: 0001776021-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $9.3M
- Remaining: $650K
- Investors: 23
- Date of first sale: 2023-02-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-475595
Issuer
- Name: BioLoomics, Inc.
- CIK: 0001776021
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 85 FORREST LANE, BOULDER, CO, 80302
- Phone: 303-927-8729
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Nicholas A Saccomano | Director | Boulder, CO |
| Douglas A Chapnick | Director | Boulder, CO |
| Douglas A Chapnick | Executive Officer | Boulder, CO |
| Douglas A Chapnick | Promoter | Boulder, CO |
| Joel A Dudley | Director | Boulder, CO |
| Douglas Chapnick | Director | Boulder, CO |
| Douglas Chapnick | Executive Officer | Boulder, CO |
Other filings by this issuer (3)
More